sun pharma (DeutscheBank) Receives US FDA approval for docetaxel, factored in our TP

US FDA approval for Sun's docetaxel branded as Docefrez; While limited competition, upside may be limited - estimate DCF of INR 7/share, which is factored in our TP of INR 430 for Sun
Date Rating Target Price Recommendation Price Broker house
5 May 2011 hold 430 443 DeutscheBank Report

No comments:

Post a Comment